DE69821524D1 - Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln - Google Patents

Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln

Info

Publication number
DE69821524D1
DE69821524D1 DE69821524T DE69821524T DE69821524D1 DE 69821524 D1 DE69821524 D1 DE 69821524D1 DE 69821524 T DE69821524 T DE 69821524T DE 69821524 T DE69821524 T DE 69821524T DE 69821524 D1 DE69821524 D1 DE 69821524D1
Authority
DE
Germany
Prior art keywords
vitis vinifera
phospholipid complex
antiatherosclerotic agents
vinifera extract
extract phospholipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69821524T
Other languages
English (en)
Other versions
DE69821524T2 (de
Inventor
Paolo Morazzoni
Ezio Bombardelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Publication of DE69821524D1 publication Critical patent/DE69821524D1/de
Application granted granted Critical
Publication of DE69821524T2 publication Critical patent/DE69821524T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/30Fuel from waste, e.g. synthetic alcohol or diesel

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69821524T 1997-12-04 1998-11-30 Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln Expired - Lifetime DE69821524T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97MI002690A IT1296920B1 (it) 1997-12-04 1997-12-04 Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
ITMI972690 1997-12-04
PCT/EP1998/007662 WO1999029331A1 (en) 1997-12-04 1998-11-30 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents

Publications (2)

Publication Number Publication Date
DE69821524D1 true DE69821524D1 (de) 2004-03-11
DE69821524T2 DE69821524T2 (de) 2005-01-05

Family

ID=11378312

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821524T Expired - Lifetime DE69821524T2 (de) 1997-12-04 1998-11-30 Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln

Country Status (23)

Country Link
US (1) US6297218B1 (de)
EP (1) EP1035859B1 (de)
JP (1) JP4456267B2 (de)
KR (1) KR100567867B1 (de)
CN (1) CN1126564C (de)
AT (1) ATE258802T1 (de)
AU (1) AU743031B2 (de)
BR (1) BR9805813B1 (de)
CA (1) CA2312795C (de)
CZ (1) CZ299555B6 (de)
DE (1) DE69821524T2 (de)
DK (1) DK1035859T3 (de)
ES (1) ES2214755T3 (de)
HK (1) HK1033267A1 (de)
HU (1) HU228109B1 (de)
IT (1) IT1296920B1 (de)
NO (1) NO324796B1 (de)
PL (1) PL191023B1 (de)
PT (1) PT1035859E (de)
RU (1) RU2207866C2 (de)
SI (1) SI1035859T1 (de)
SK (1) SK284865B6 (de)
WO (1) WO1999029331A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1304183B1 (it) * 1998-12-18 2001-03-08 Indena Spa Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
JP2001122791A (ja) 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
JP4574788B2 (ja) 2000-03-24 2010-11-04 協和発酵バイオ株式会社 プロアントシアニジン含有組成物
IT1320080B1 (it) * 2000-10-25 2003-11-18 Giuliani Spa Composizione per uso farmaceutico o dietetico.
FR2836337B1 (fr) * 2002-02-28 2004-11-19 Bio Serae Laboratoires Utilisation des polymeres procyanidoliques a titre d'agents inhibuteurs des alpha-amylases et application dans des compositions a visees dietetiques
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
JP4989071B2 (ja) * 2002-12-31 2012-08-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 赤ブドウ葉抽出物を含むフィルムコート錠
ITMI20031313A1 (it) * 2003-06-27 2004-12-28 Indena Spa Associazioni di agenti vasoprotettori e formulazioni che li contengono.
EP1550450A1 (de) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben und einem Blutumlauf verbesserndes Mittel
CA2551787C (en) 2004-02-19 2014-04-08 Boehringer Ingelheim International Gmbh Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent
US20060088617A1 (en) * 2004-10-23 2006-04-27 Mccurry James M Chocolate composition and method for benefiting the cardiovascular system
AT501682A1 (de) 2005-01-14 2006-10-15 Hermine Dr Engl Verfahren zur herstellung einer wirkstoffmischung
EP1837030A1 (de) 2006-03-09 2007-09-26 INDENA S.p.A. Curcumin-phospholipid-Komplexe mit verbesserter Bioverfügbarkeit
EP2829277A1 (de) 2013-07-26 2015-01-28 Natac Biotech, S.L. Verwendung von A-Typ-Proanthocyanidinen bei der Behandlung einer Erkrankung in Zusammenhang mit dem Mineralocorticoidrezeptor
AU2018360383A1 (en) 2017-11-02 2020-05-21 Natureceuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092743A1 (en) * 1970-06-15 1972-01-28 Aquitaine Invest Pharma Complete extraction of total flavanol gomers from plats -peripheral - venous activity
GB1541469A (en) * 1976-12-01 1979-02-28 Inverni Della Beffa Spa Method of obtaining flavonolic oligomers
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
US5484594A (en) * 1988-06-28 1996-01-16 Tecnofarmaci S.P.A. Process for preparing grapeseed extracts enriched in procyanidol oligomers
FI955691A (fi) * 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet

Also Published As

Publication number Publication date
HUP0100522A2 (hu) 2001-12-28
CA2312795A1 (en) 1999-06-17
EP1035859B1 (de) 2004-02-04
NO324796B1 (no) 2007-12-10
JP2001525370A (ja) 2001-12-11
WO1999029331A1 (en) 1999-06-17
SK284865B6 (sk) 2006-01-05
CA2312795C (en) 2009-01-20
CN1126564C (zh) 2003-11-05
NO20002827L (no) 2000-06-02
ATE258802T1 (de) 2004-02-15
EP1035859A1 (de) 2000-09-20
BR9805813A (pt) 1999-12-14
IT1296920B1 (it) 1999-08-03
DE69821524T2 (de) 2005-01-05
KR100567867B1 (ko) 2006-04-04
BR9805813B1 (pt) 2009-05-05
HK1033267A1 (en) 2001-08-24
SI1035859T1 (en) 2004-04-30
HU228109B1 (en) 2012-11-28
ITMI972690A1 (it) 1999-06-04
CN1280498A (zh) 2001-01-17
PL340884A1 (en) 2001-03-12
NO20002827D0 (no) 2000-06-02
AU743031B2 (en) 2002-01-17
CZ299555B6 (cs) 2008-09-03
AU1562799A (en) 1999-06-28
US6297218B1 (en) 2001-10-02
KR20010024654A (ko) 2001-03-26
RU2207866C2 (ru) 2003-07-10
ES2214755T3 (es) 2004-09-16
SK8272000A3 (en) 2000-11-07
HUP0100522A3 (en) 2002-04-29
DK1035859T3 (da) 2004-05-17
PL191023B1 (pl) 2006-03-31
JP4456267B2 (ja) 2010-04-28
PT1035859E (pt) 2004-05-31
CZ20002038A3 (cs) 2000-12-13

Similar Documents

Publication Publication Date Title
DE69821524D1 (de) Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln
ES2164916T3 (es) Tratamiento de la esclerosis multiple.
ATE181231T1 (de) Verfahren zur hautpflege und mittel
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
ATE312597T1 (de) Verwendung von nanodispersionen in pharmazeutischen endformulierungen
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
DE69717148T2 (de) 3-pyridylenantiomere und ihre verwendung als analgetika
DE69822496D1 (de) Lipidkomplex-lyophilisat von wasserunlöslichen porphyrinen
DE59812513D1 (de) Verwendung von W/O-Emulsionen als Verdicker in kosmetischen und pharmazeutischen Zubereitungen
ATE251888T1 (de) Rosaceae extrakt als bradykinin-antagonist
NO912435L (no) Farmasoeytiske preparater.
DE69526350D1 (de) Abschuppungs-zusammensetzung
DE69230644T2 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
AU1871497A (en) An aphrodisiac for application to the sexual organs
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
FR2710266B1 (fr) Nouvelles compositions en cosmétologie et dermatologie proposées dans le traitement des verrues.
EP1173186A4 (de) Verwendung von tagatose zur verbesserung wichtiger blutfaktoren
RU94024337A (ru) Антиметастатическое средство
NO984198D0 (no) Fremgangsmåte for behandling av aggresjon
RU96102110A (ru) Способ профилактики и лечения изъязвлений роговицы
GEU1998402Y (en) Means for Treatment of Skin Cancer - “Khvedelidze Ointment”
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
DE50007222D1 (de) Verwendung von hydroxyethern in kosmetischen und pharmazeutischen zubereitungen
UA10435A (uk) Спосіб стимуляції життєдіяльhості людиhи та пристрій для його здійсhеhhя
GEP20012408B (en) Means for Treatment of Psoriasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC